Literature DB >> 16675555

Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism.

J Michael Mathis1, Phoebe L Stewart, Zheng B Zhu, David T Curiel.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16675555      PMCID： PMC2203211          DOI： 10.1158/1078-0432.CCR-06-0497

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  61 in total

1.  Structure of adenovirus fibre. II. Morphology of single fibres.

Authors:  R W Ruigrok; A Barge; C Albiges-Rizo; S Dayan
Journal:  J Mol Biol       Date:  1990-10-20       Impact factor: 5.469

2.  Structure of adenovirus fibre. I. Analysis of crystals of fibre from adenovirus serotypes 2 and 5 by electron microscopy and X-ray crystallography.

Authors:  C Devaux; M Adrian; C Berthet-Colominas; S Cusack; B Jacrot
Journal:  J Mol Biol       Date:  1990-10-20       Impact factor: 5.469

3.  Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

Authors:  V N Krasnykh; G V Mikheeva; J T Douglas; D T Curiel
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

4.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

5.  Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells.

Authors:  S S Hong; L Karayan; J Tournier; D T Curiel; P A Boulanger
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

6.  Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

Authors:  T J Wickham; P Mathias; D A Cheresh; G R Nemerow
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

7.  Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain.

Authors:  S C Stevenson; M Rollence; B White; L Weaver; A McClelland
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Adenovirus 3 penton dodecahedron exhibits structural changes of the base on fibre binding.

Authors:  G Schoehn; P Fender; J Chroboczek; E A Hewat
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

9.  Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli.

Authors:  L J Henry; D Xia; M E Wilke; J Deisenhofer; R D Gerard
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

Review 10.  New developments in the virus therapy of cancer: a historical review.

Authors:  J Sinkovics; J Horvath
Journal:  Intervirology       Date:  1993       Impact factor: 1.763
View more
  6 in total

1.  Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo.

Authors:  Cédric Sapet; Christophe Pellegrino; Nicolas Laurent; Flavie Sicard; Olivier Zelphati
Journal:  Pharm Res       Date:  2011-12-07       Impact factor: 4.200

2.  Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy.

Authors:  Xinglei Yao; Yasuo Yoshioka; Tomohiro Morishige; Yusuke Eto; Shogo Narimatsu; Yasuaki Kawai; Hiroyuki Mizuguchi; Jian-Qing Gao; Yohei Mukai; Naoki Okada; Shinsaku Nakagawa
Journal:  Mol Ther       Date:  2011-06-14       Impact factor: 11.454

3.  Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer.

Authors:  Yuanqing Wu; Bingliang Fang; Xiulan Q Yang; Li Wang; Dongning Chen; Victor Krasnykh; Bing Z Carter; Jeffrey S Morris; Imad Shureiqi
Journal:  Mol Ther       Date:  2008-03-18       Impact factor: 11.454

4.  Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors.

Authors:  Meredith A Preuss; Joel N Glasgow; Maaike Everts; Mariam A Stoff-Khalili; Hongju Wu; David T Curiel
Journal:  Open Gene Ther J       Date:  2008-01-01

5.  Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.

Authors:  Belal Azab; Rupesh Dash; Swadesh K Das; Sujit K Bhutia; Xue-Ning Shen; Bridget A Quinn; Siddik Sarkar; Xiang-Yang Wang; Michael Hedvat; Igor P Dmitriev; David T Curiel; Steven Grant; Paul Dent; John C Reed; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

Review 6.  Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.

Authors:  Swadesh K Das; Siddik Sarkar; Rupesh Dash; Paul Dent; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.